MK-801 reduces retinal ganglion cell survival but improves visual performance after controlled optic nerve crush

Journal of Neurotrauma

Volumn 13, Issue 12, 1996, Pages 791-800

  Schmitt, Ulrich ^a   Sabel, Bernhard A ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

behavior; functional recovery; MK 801; optic nerve crush; rat; retinal ganglion cells

Indexed keywords

DIZOCILPINE; HORSERADISH PEROXIDASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CRUSH TRAUMA; INTRAOCULAR DRUG ADMINISTRATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OPTIC NERVE LESION; RAT; RETINA GANGLION CELL; VISION; VISUAL DISCRIMINATION;

EID: 0030467437     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1996.13.791     Document Type: Article

References (50)

1. ALLCUTT, D., BERRY, M., and SIEVERS, J. (1984). A quantitative comparison of the reactions of retinal ganglion cells to optic nerve crush in neonatal and adult mice. Dev. Brain Res. 16, 219-230.
2. AUER, R.N., and COULTER, K.C. (1994). The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801. Acta Neuropathol. Berl. 87, 1-7.
3. BALAZS, R., HACK, N., and JORGENSEN, O.S. (1990). Interactive effects involving different classes of excitatory amino acid receptors and the survival of cerebellar granule cells in culture. Int. J. Dev. Neurosci. 8, 347-359.
4. BARRON, K.D., DENTINGER, M.P., KROHEL, G., EASTON, S.K., and MANKES, R. (1986). Qualitative and quantitative ultrastructural observations on retinal ganglion cell layer of rat after intraorbital nerve crush. J. Neurocytol. 15, 345-362.
5. BARTH, T.M., GRANT, M.L., and SHALLERT, T. (1990). Effects of MK-801 on recovery from sensorimotor cortex lesions. Stroke 21, 153-157.
6. BEATTIE, M.S., STOKES, B.T., and BRESHNAHAN, J.C. (1988). Experimental spinal cord injury: Strategies for acute and chronic intervention based on anatomic, physiological, and behavioral studies, in: Pharmacological Approaches to the Treatment of Brain and Spinal Cord Injury. D.G. Stein and B.A. Sabel (eds.) Plenum Press: New York, pp. 43-74.
7. BUCHAN, A., LI, H., and PULSINELLI, W.A. (1991). The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J. Neurosci. 11, 1049-1056.
8. CHOI, D.W. (1992). Excitotoxic cell death. J. Neurobiol. 23, 1261-1276.
9. DEZSI, L., GREENBERG, J.H., HAMAR, J., SLADKY, J., KARP, A., and REIVICH, M. (1992). Acute improvement in histological outcome by MK-801 following focal cerebral ischemia and reperfusion in the cat independent of blood flow changes. J. Cereb. Blood Flow Metab. 12, 390-399.
10. DREYER, E.B., PAN, Z.H., STROM, S., and LIPTON, S.A. (1994). Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. Neuroreport 5, 629-631.
11. EL ASRAR, A.M., MORSE, P.H., MAIMONE, D., TORCZYNSKI, E., and REDER, A.T. (1992). MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. Invest. Ophthalmol. Vis. Sci. 33, 3463-3468.
12. GALAMBOS, R., NORTON, T.T., and FROMMER, G.P. (1967). Optic tract lesions sparing pattern vision in cats. Exp. Neurol. 18, 8-25.
13. GENNARELLI, T.A., THIBAULT, L.E.,TIPPERMANN, R., et al. (1989). Axonal injury in the optic nerve: A model simulating diffuse axonal injury in the brain. J. Neurosurg. 71, 244-253.
14. GILL, R., FOSTER, A.C., and WOODRUFF, G.N. (1988). MK-801 is neuroprotective in gerbils when administrated during the post-ischemic period. Neuroscience 25, 847-855.
15. GILL, P., and KEMP, F.A. (1989). Protection of CA1 pyramidal cell function by MK-803 following ischemia in the gerbil. Neurosci. Lett. 105, 101-106.
16. GOULD, E., CAMERON, H.A., and MCEWEN, B.S. (1994). Blockade of NMDA receptors increases cell death and birth in the developing rat dentate gyms. J. Comp. Neurol. 340, 551-565.
17. HANKER, J.S., YATES, P.E., METZ, C.B., and RUSTONI, A. (1977). A new specific, sensitive and noncarcinogenic reagent for the demonstration of horseradish peroxidase. J. Histochem. 9, 789-792.
18. HAO, J.X., WATSON, B.D., XU, X.J., WIESENFELDHALLIN, Z., SEIGER, A., and SUNDSTROM, E. (1992). Protective effect of the NMDA antagonist MK-801 on photochemically induced spinal lesions in the rat. Exp. Neurol. 118, 143-152.
19. HOLTZ, A., and GERDIN, B. (1991). MK-801, an OBS N-methyl-D-aspartate channel blocker, does not improve the functional recovery nor spinal cord blood flow after spinal cord compression in rats. Acta Neurol. Scand. 84, 334-338.
20. LEVY, D.I., and LIPTON, S.A. (1990). Comparison of delayed administration of competitive and uncompetitive antagonists in preventing NMDA receptor-mediated neuronal death. Neurology 40, 852-855.
21. LEVY, D.I., SUCHER, N.J., and LIPTON, S.A. (1991). Glutathione prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Neuroreport 2, 345-347.
22. MARTINEZ-ARIZALA, A., RIGAMONTI, D.D., LONG, J.B., KRAIMER, J.M., and HOLADAY, J.W. (1990). Effects of NMDA receptor antagonists following spinal ischemia in the rabbit. Exp. Neurol. 108, 232-240.
23. MAXWELL, W.L., ISLAM, M.W., GRAHAM, D.I., and GENNARELLI, T.A. (1994). A qualitative and quantitative analysis of the response of the retinal ganglion cell soma after stretch injury to the adult guinea-pig optic nerve. J. Neurocytol. 23, 379-392.
24. MCINTOSH, T.K., VINK, R., NOBLE, L., YAMAKAMI, I., FERNYAK, S., SOARES, H., and FADEN, A.L. (1989a). Traumatic brain injury in the rat: Characterization of a lateral fluid-percussion model. Neuroscience 28, 233-244.
25. McINTOSH, T.K., VINK, R., SOARES, H., HAYES, R., and SIMON, R. (1989b). Effects of the N-methyl-D-aspartate receptor blocker MK-801 on neurologic function after experimental brain injury. J. Neurotrauma 6, 247-259.
26. MICHAELS, R.L., and ROTHMAN, S.M. (1990). Glutamate neurotoxicity in vitro: Antagonist pharmacology and intracellular calcium concentrations. J. Neurosci. 10, 283-292.
27. MISANTONE, L.J., GERSHENBAUM, M., and MURRAY, M. (1984). Viability of retinal ganglion cells after optic nerve crush in adult rats. J. Neurocytol. 13, 449-465.
28. NELLGARD, B., GUSTAFSON, I., and WIELOCH, T. (1991). Lack of protection by the N-methyl-D-aspartate receptor blocker dizocilipine (MK-801) after transient severe cerebral ischemia in the rat. Anesthesiology 75, 279-287.
29. OLNEY, J.W. (1969). Brain lesion, obesity and other disturbances in mice treated with monosodium glutamate. Science 164, 719-721.
30. OLNEY, J.W., PRICE, M.T., SAMSON, L., and LABRUYERE, J. (1986). The role of specific ions in glutamate neurotoxicity. Neurosci. Lett. 65, 65-71.
31. OLUCHA, F., MARTINEZ-GARCIA, F., and LOPEZ-GARCIA, C. (1985). A new stabilizing agent for the tetramethyl benzidine (TMB) reaction product in the histochemical detection of horseradish peroxidase. J. Neurosci. Methods 13, 131-138.
32. PAXINOS, G., and WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press: San Diego, CA.
33. PERRY, V.H. (1979). The ganglion cell layer of the retina of the rat: A Golgi study. Proc. R. Soc. Lond. B 204, 363-375.
34. PERRY, V.H., and COWEY, A. (1982). A sensitive period for ganglion cell degeneration and the formation of aberrant retino-fugal connections following tectal lesions in rats. Neuroscience 7, 583-594.
35. RAMIREZ, J.J., and SABEL, B.A. (1990). Toward an unified theory of ganglioside-mediated functional restoration after brain injury: Lesion size not lesion site is the primary factor determining efficacy. Acta Neurobiol, Exp. 50, 415-438.
36. ROGERS, B.C., and TILSON, H.A. (1989). MK-801 prevents cognitive and behavioral deficits produced by NMDA receptor overstimulation in the rat hippocampus. Toxicol. Appl. Pharmacol. 99, 445-453.
37. ROTHMAN, S.M., and OLNEY, J.W. (1987). Excitotoxicity and the NMDA receptor. TINS 10, 299-302.
38. SABEL, B.A., SAUTTER, J., STOEHR, T., and SILIPRANDI, R. (1995). A behavioral model of excitotoxicity: Retinal degeneration, loss of vision, and subsequent recovery after intraocular NMDA-administration in adult rats. Exp. Brain Res. 106, 93-105.
39. SAUTTER, J., and SABEL, B.A. (1993). Recovery of brightness discrimination in adult rats despite progressive loss of retrogradely labelled retinal ganglion cells after controlled optic nerve crush. Eur. J. Neurosci. 5, 680-690.
40. SAUTTER, J., SCHWARTZ, M., DUVDEVANI, R., and SABEL, B.A. (1991). GM1 ganglioside treatment reduces visual deficits after graded crush of the rat optic nerve. Brain Res. 565, 23-33.
41. SCHMTTT, U., CROSS, R., PAZDERNIK, T.L., and SABEL, B.A. (1996). Loss and subsequent recovery of local cerebral glucose use in visual targets after controlled optic nerve crush injury in adult rats. Exp. Neurol. 139, 17-24.
42. SCHMITT, U., and SABEL, B.A. (1996). Basic fibroblast growth factor improves functional recovery after controlled optic nerve crush without increasing retinal ganglion cell survival. Res. Neurol. Neurosci. 10, 61-68.
43. SCHWARCZ, R., and COYLE, J.T. (1977). Kainic acid: Neurotoxic effects of intraocular injection. Invest. Ophthal. Vis. Sci. 16, 141-168.
44. SHARP, F.R., JASPER, P., HALL, J., NOBLE, L., and SAGAR, S.M. (1991). MK-801 and ketamine induced heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann. Neurol. 30, 801-809.
45. SILIPRANDI, R., CANELLA, R., CARMIGNOTO, G., SCHIAVIO, N., ZANELLATO, A., ZANONI, R., and VANTINI, G. (1992). N-Methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis. Neurosci. 8, 567-573.
46. +] in the hippocampus during recovery from short-term, transient ischemia. J. Cereb. Blood Flow Metab. 12, 759-772.
47. THANOS, S. (1988). Alterations in the morphology of ganglion cell dendrites in the adult rat retina after optic nerve transection and grafting of peripheral nerve segments. Cell Tissue Res. 254, 599-609.
48. THANOS, S., and MEY, J. (1995). Type-specific stabilization and target-dependent survival of regenerating ganglion cells in the retina of adult rats. J. Neurosci. 15, 1057-1079.
49. VON LUBITZ, D.K., MCKENZIE, R.J., LIN, R.C., DEVLIN, T.M., and SKOLNICK, P. (1993). MK-801 is neuroprotective but does not improve survival in severe forebrain ischemia. Eur. J. Pharmacol. 233, 95-100.
50. ZIGMOND, M.J., ACHESON, A.L., STACHOWIAK, M.K., and STRICKER, E.M. (1984). Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch. Neurol. 41, 856-861.